Incidence of Extrusion Following Type I Polypropylene Mesh “Kit” Repairs in the Correction of Pelvic Organ Prolapse
Table 4
Outcome variables for subjects with and without extrusion (AC or PC/A).
Variable1
Baseline extrusion
Baseline nonextrusion
12-Month extrusion
12-Month nonextrusion
value (within group)2
value (between groups)3
Anterior compartment
POPQ
NA
NA
Anterior stage ≥ II
(100.0%)
(100.0%)
(8.3%)
(16.4%)
NA
0.692
Wong-Baker
0.781
0.685
Pain score 4
()
()
()
()
<.001
0.228
PFDI (symptoms)
0.024
0.243
Anterior POPDI
()
()
()
()
<.001
0.715
PFDI (symptoms)
<.001
0.075
UDI
()
()
()
()
<.001
0.523
PFIQ-7 (life impact)
0.008
0.186
POPIQ
()
()
()
()
<.001
0.267
PFIQ-7 (life impact)
0.061
0.211
UIQ
()
()
()
()
<.001
0.158
PISQ-12
0.151
0.693
(If sexually active)
()
()
()
()
<.001
0.149
Dyspareunia
1.000
0.745
(From PISQ-12, number 5)
(50.0%)
(43.4%)
(62.5%)
(29.9%)
0.491
0.108
Posterior compartment/Apex
POPQ
0.180
0.629
Apical stage ≥ II
(18.5%)
(25.0%)
(4.3%)
(2.8%)
<.001
0.535
POPQ
NA
1.000
Posterior stage ≥ II
(100.0%)
(97.0%)
(0.0%)
(5.0%)
<.001
0.595
Wong-Baker
0.367
0.094
Pain score 4
()
()
()
()
<.001
0.409
PFDI (symptoms)
0.001
0.863
POPDI posterior
()
()
()
()
<.001
0.242
PFDI (symptoms)
<.001
0.759
CRADI
()
()
()
()
<.001
0.204
PFIQ-7 (life impact)
<.001
0.637
POPIQ
()
()
()
()
<.001
0.432
PFIQ-7 (life impact)
0.093
0.415
CRAIQ
()
()
()
()
<.001
0.105
PISQ-12
0.046
0.592
(If sexually active)
()
()
()
()
<.001
0.323
Dyspareunia
0.083
0.782
(From PISQ-12, number 5)
(46.7%)
(41.0%)
(20.0%)
(33.7%)
0.450
0.376
1Values are presented as (%) or Mean ± SD; NA: Not Available. 2 value paired comparison between baseline and 12 Months for the extrusion group and nonextrusion group. 3 value unpaired comparison between extrusion group and nonextrusion group for the baseline time-point and the 12-month time-point. 4Data at 3-month followup (Wong-Baker FACES pain scores were not collected at 12-month).